Azenta Price to Sales Ratio 2011-2025 | AZTA
Historical PS ratio values for Azenta (AZTA) over the last 10 years. The current P/S ratio for Azenta as of November 14, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Azenta P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2025-11-14 | 29.75 | 2.14 | |
| 2025-06-30 | 30.78 | $13.91 | 2.21 |
| 2025-03-31 | 34.64 | $13.49 | 2.57 |
| 2024-12-31 | 50.00 | $12.82 | 3.90 |
| 2024-09-30 | 48.44 | $12.08 | 4.01 |
| 2024-06-30 | 52.62 | $10.28 | 5.12 |
| 2024-03-31 | 60.28 | $10.18 | 5.92 |
| 2023-12-31 | 65.14 | $9.86 | 6.60 |
| 2023-09-30 | 50.19 | $9.82 | 5.11 |
| 2023-06-30 | 46.68 | $9.06 | 5.15 |
| 2023-03-31 | 44.62 | $8.21 | 5.43 |
| 2022-12-31 | 58.22 | $8.01 | 7.27 |
| 2022-09-30 | 42.86 | $7.41 | 5.78 |
| 2022-06-30 | 72.10 | $7.41 | 9.72 |
| 2022-03-31 | 82.88 | $7.38 | 11.23 |
| 2021-12-31 | 103.11 | $7.18 | 14.35 |
| 2021-09-30 | 102.26 | $6.91 | 14.80 |
| 2021-06-30 | 95.08 | $1.52 | 62.68 |
| 2021-03-31 | 81.40 | $2.76 | 29.46 |
| 2020-12-31 | 67.56 | $4.00 | 16.88 |
| 2020-09-30 | 46.00 | $5.27 | 8.73 |
| 2020-06-30 | 43.91 | $5.41 | 8.12 |
| 2020-03-31 | 30.20 | $5.24 | 5.77 |
| 2019-12-31 | 41.43 | $5.00 | 8.29 |
| 2019-09-30 | 36.47 | $4.62 | 7.89 |
| 2019-06-30 | 38.06 | $10.29 | 3.70 |
| 2019-03-31 | 28.73 | $9.91 | 2.90 |
| 2018-12-31 | 25.57 | $9.39 | 2.72 |
| 2018-09-30 | 34.08 | $8.91 | 3.82 |
| 2018-06-30 | 31.66 | $6.90 | 4.59 |
| 2018-03-31 | 26.20 | $7.05 | 3.72 |
| 2017-12-31 | 22.99 | $7.24 | 3.17 |
| 2017-09-30 | 29.14 | $7.52 | 3.88 |
| 2017-06-30 | 20.74 | $7.74 | 2.68 |
| 2017-03-31 | 21.34 | $7.29 | 2.93 |
| 2016-12-31 | 16.19 | $6.85 | 2.36 |
| 2016-09-30 | 12.83 | $6.32 | 2.03 |
| 2016-06-30 | 10.49 | $7.99 | 1.31 |
| 2016-03-31 | 9.64 | $7.97 | 1.21 |
| 2015-12-31 | 9.80 | $8.04 | 1.22 |
| 2015-09-30 | 10.65 | $8.10 | 1.31 |
| 2015-06-30 | 10.31 | $7.79 | 1.32 |
| 2015-03-31 | 10.38 | $7.41 | 1.40 |
| 2014-12-31 | 11.29 | $7.24 | 1.56 |
| 2014-09-30 | 9.22 | $7.16 | 1.29 |
| 2014-06-30 | 9.37 | $6.92 | 1.35 |
| 2014-03-31 | 9.43 | $6.85 | 1.38 |
| 2013-12-31 | 8.98 | $6.65 | 1.35 |
| 2013-09-30 | 7.91 | $6.40 | 1.24 |
| 2013-06-30 | 8.19 | $6.17 | 1.33 |
| 2013-03-31 | 8.50 | $6.65 | 1.28 |
| 2012-12-31 | 6.67 | $7.10 | 0.94 |
| 2012-09-30 | 6.59 | $7.45 | 0.89 |
| 2012-06-30 | 7.67 | $8.11 | 0.95 |
| 2012-03-31 | 9.93 | $8.83 | 1.12 |
| 2011-12-31 | 8.21 | $9.67 | 0.85 |
| 2011-09-30 | 6.46 | $10.60 | 0.61 |
| 2011-06-30 | 8.53 | $11.42 | 0.75 |
| 2011-03-31 | 10.79 | $11.00 | 0.98 |
| 2010-12-31 | 7.13 | $10.35 | 0.69 |
| 2010-09-30 | 5.27 | $9.26 | 0.57 |
| 2010-06-30 | 6.07 | $7.44 | 0.82 |
| 2010-03-31 | 6.93 | $5.70 | 1.22 |
| 2009-12-31 | 6.74 | $3.98 | 1.69 |
| 2009-09-30 | 6.07 | $3.48 | 1.75 |
| 2009-06-30 | 3.52 | $4.12 | 0.85 |
| 2009-03-31 | 3.62 | $5.41 | 0.67 |
| 2008-12-31 | 4.57 | $7.12 | 0.64 |
| 2008-09-30 | 6.57 | $8.09 | 0.81 |
| 2008-06-30 | 6.50 | $8.68 | 0.75 |
| 2008-03-31 | 7.64 | $9.21 | 0.83 |
| 2007-12-31 | 10.38 | $9.49 | 1.09 |
| 2007-09-30 | 11.19 | $9.90 | 1.13 |
| 2007-06-30 | 14.26 | $10.23 | 1.39 |
| 2007-03-31 | 13.48 | $9.91 | 1.36 |
| 2006-12-31 | 11.32 | $9.31 | 1.21 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.370B | $0.656B |
| Azenta Inc. is a provider of life sciences solutions. The company provides reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the pharmaceutical, biotech, academic and healthcare institutions. Azenta Inc., formerly known as Brooks Automation Inc., is based in CHELMSFORD, Mass. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $47.812B | 58.34 |
| Tempus AI (TEM) | United States | $11.803B | 0.00 |
| Doximity (DOCS) | United States | $9.361B | 38.54 |
| Hims & Hers Health (HIMS) | United States | $8.207B | 66.76 |
| IRhythm Technologies (IRTC) | United States | $5.429B | 0.00 |
| Hinge Health (HNGE) | United States | $3.287B | 0.00 |
| Privia Health (PRVA) | United States | $2.921B | 182.69 |
| Heartflow (HTFL) | United States | $2.635B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.522B | 41.72 |
| 10x Genomics (TXG) | United States | $2.035B | 0.00 |
| Enovis (ENOV) | United States | $1.765B | 9.27 |
| Omnicell (OMCL) | United States | $1.596B | 32.62 |
| Phreesia (PHR) | United States | $1.350B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.276B | 0.00 |
| Schrodinger (SDGR) | United States | $1.267B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.915B | 0.00 |
| Claritev (CTEV) | United States | $0.730B | 0.00 |
| Talkspace (TALK) | United States | $0.535B | 107.67 |
| Veradigm (MDRX) | United States | $0.534B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.523B | 0.00 |
| Evolent Health (EVH) | United States | $0.464B | 0.00 |
| Standard BioTools (LAB) | United States | $0.461B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.365B | 0.00 |
| Carlsmed (CARL) | United States | $0.338B | 0.00 |
| TruBridge (TBRG) | United States | $0.306B | 14.08 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.296B | 0.00 |
| CapsoVision (CV) | United States | $0.265B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.225B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.202B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.188B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.181B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.166B | 0.00 |
| CareCloud (CCLD) | United States | $0.135B | 7.40 |
| EUDA Health Holdings (EUDA) | Singapore | $0.113B | 0.00 |
| Outset Medical (OM) | United States | $0.089B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.076B | 0.00 |
| Pulmonx (LUNG) | United States | $0.066B | 0.00 |
| American Well (AMWL) | United States | $0.065B | 0.00 |
| HeartBeam (BEAT) | United States | $0.054B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.050B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.036B | 0.00 |
| 111 (YI) | China | $0.035B | 0.00 |
| Precipio (PRPO) | United States | $0.032B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.027B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.024B | 0.00 |
| Zhongchao (ZCMD) | China | $0.017B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.013B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.010B | 0.00 |
| Movano (MOVE) | United States | $0.009B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.002B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.001B | 0.00 |